Cargando…

Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy

BACKGROUND: The worldwide prevalence of obesity is increasing. Obesity is associated with a variety of chronic diseases, including chronic kidney disease. Several studies suggested that body mass index (BMI) could be an independent risk factor for progression of IgA nephropathy (IgAN). However, whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Changwei, Wang, Amanda Y., Li, Guisen, Wang, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310977/ https://www.ncbi.nlm.nih.gov/pubmed/30594167 http://dx.doi.org/10.1186/s12882-018-1164-2

Ejemplares similares

The interaction effect of rs4077515 and rs17019602 increases the susceptibility to IgA nephropathy
por: Wu, Changwei, et al.
Publicado: (2017)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023)

Lipidomics reveals association of circulating lipids with body mass index and outcomes in IgA nephropathy patients
por: Deng, Yueyi, et al.
Publicado: (2021)

Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy
por: Jia, Wanyu, et al.
Publicado: (2023)

Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy
por: Guan, Jie, et al.
Publicado: (2023)

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy
por: Sonoda, Yuji, et al.
Publicado: (2015)

p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients
por: Lee, Jeonghwan, et al.
Publicado: (2019)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Serum homocysteine is associated with tubular interstitial lesions at the early stage of IgA nephropathy
por: Li, Zizhen, et al.
Publicado: (2022)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

IgA Nephropathy that Developed as an Immune-related Adverse Event of Pembrolizumab Complicated with Interstitial Nephritis
por: Mitarai, Yuki, et al.
Publicado: (2021)

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
por: Berthelot, Laureline, et al.
Publicado: (2012)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Immunological Pattern in IgA Nephropathy
por: Esteve Cols, Clara, et al.
Publicado: (2020)

Tripterygium Wilfordii inhibits tonsillar IgA production by downregulating IgA class switching in IgA nephropathy
por: Li, Huining, et al.
Publicado: (2017)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

Tuberculosis-associated IgA nephropathy
por: Wang, Yamei, et al.
Publicado: (2018)

Left ventricular myocardial mass index associated with cardiovascular and renal prognosis in IgA nephropathy
por: Sági, Balázs, et al.
Publicado: (2022)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy
por: Zhou, Jingjing, et al.
Publicado: (2014)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

IgA Nephropathy Secondary to Ipilimumab Use
por: Dougherty, Sean C., et al.
Publicado: (2021)

Noninvasive evaluation of IgA nephropathy fibrosis using Doppler ultrasound
por: Qin, Xiachuan, et al.
Publicado: (2022)

Development and validation of a prognostic nomogram for IgA nephropathy
por: Liu, Jian, et al.
Publicado: (2017)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

A Validation Study Comparing Risk Prediction Models of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2021)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Serum Levels of Joining Chain-Containing IgA1 Are Not Elevated in Patients with IgA Nephropathy
por: Li, Guanhong, et al.
Publicado: (2019)

Development and assessment of a predictive nomogram for the progression of IgA nephropathy
por: Liu, Lin-lin, et al.
Publicado: (2018)

The genetic variants at the HLA-DRB1 gene are associated with primary IgA nephropathy in Han Chinese
por: Jiyun, Yang, et al.
Publicado: (2012)

IgA nephropathy with podocytic infolding glomerulopathy
por: Wang, Zhouyang, et al.
Publicado: (2023)

Randomized Phase 2 Trial of Telitacicept in Patients With IgA Nephropathy With Persistent Proteinuria
por: Lv, Jicheng, et al.
Publicado: (2022)

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?
por: He, Jia-Wei, et al.
Publicado: (2023)

A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study
por: Chen, Shasha, et al.
Publicado: (2018)

Immunological abnormalities in patient with IgA nephropathy.
por: Ihm, C. G., et al.
Publicado: (1986)

Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience
por: SU, QingXiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3l2hp8d435s1olvmd5n1eg0d9l